老虎证券
Invest
Pricing
Rewards
Support
Learn
About
Quotes
TigerAI
登录
立即注册
Toggle
港股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
杭州德适生物科技股份有限公司(临时代码)
成交量:
- -
成交额:
- -
市值:
- -
市盈率:
- -
高:
- -
开:
- -
低:
- -
收:
- -
52周最高:
- -
52周最低:
- -
股本:
- -
香港流通股本:
- -
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
市销率:
- -
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
医学影像大模型第一股来了?德适生物港股IPO获证监会备案
市场资讯
·
01/07
【新股IPO】杭州德适生物科技股份有限公司 - B向港交所主板提交上市申请
金吾财讯
·
01/07
新股消息 | 德适生物港股IPO及境内未上市股份“全流通”获中国证监会备案
智通财经
·
01/05
新股消息 | 德适生物港股IPO招股书失效
智通财经
·
2025/12/29
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/91016"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"91016","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"91016\",,,,,undefined,":{"symbol":"91016","market":"HK","secType":"STK","nameCN":"杭州德适生物科技股份有限公司(临时代码)","latestPrice":0,"timestamp":1770796800000,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0,"latestTime":"02-11 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770859800000},"marketStatusCode":5,"adr":0,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1770773400000,1770782400000],[1770786000000,1770796800000]],"volumeRatio":0,"lotSize":100,"spreadScale":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"91016\",,,,,undefined,":{"symbol":"91016","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/91016\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"91016\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"91016\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"91016\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601878911","title":"医学影像大模型第一股来了?德适生物港股IPO获证监会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2601878911","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601878911?lang=zh_cn&edition=fundamental","pubTime":"2026-01-07 15:00","pubTimestamp":1767769200,"startTime":"0","endTime":"0","summary":" 2026年1月5日,中国证监会发布备案通知,杭州德适生物科技股份有限公司正式获批境外发行上市及境内未上市股份“全流通”。这意味着,这家深耕医学影像人工智能、软件研发与高端医疗装备的企业,即将登陆港交所,有望成为全球首家以“医学影像大模型”为核心资产的上市公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-01-07/doc-inhfnktr4756891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02251","BK1189","91016"],"gpt_icon":0},{"id":"2601819190","title":"【新股IPO】杭州德适生物科技股份有限公司 - B向港交所主板提交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2601819190","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601819190?lang=zh_cn&edition=fundamental","pubTime":"2026-01-07 00:01","pubTimestamp":1767715302,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所1月6日披露,杭州德适生物科技股份有限公司 - B向港交所主板提交上市申请,华泰国际为独家保荐人。公司成立于2016年,是一家专注于开发医学影像产品及服务的医疗器械公司。公司核心产品AI AutoVision是一款染色体核型辅助诊断软件,专为执行染色体核型智能分析而设计。AI AutoVision于2025年5月获国家药监局认定为“三类创新医疗器械”,可享受加速监管审批流程。同月,公司向国家药监局提交第三类医疗器械注册申请。","market":"sh","thumbnail":"https://static.szfiu.com/news/20220324/MzRhMTE1MTUwMjgzODI3Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/MzRhMTE1MTUwMjgzODI3Nw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1972700","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEXmain","91016"],"gpt_icon":0},{"id":"2601866678","title":"新股消息 | 德适生物港股IPO及境内未上市股份“全流通”获中国证监会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2601866678","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601866678?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 20:01","pubTimestamp":1767614473,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,1月5日,中国证监会国际合作司发布《关于杭州德适生物科技股份有限公司境外发行上市及境内未上市股份“全流通”备案通知书》。该公司27名股东拟将所持合计8088万股境内未上市股份转为境外上市股份,并在香港联合交易所上市流通。据招股书披露,德适生物一直专注医学影像AI行业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388822.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["91016"],"gpt_icon":0},{"id":"2595784449","title":"新股消息 | 德适生物港股IPO招股书失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2595784449","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595784449?lang=zh_cn&edition=fundamental","pubTime":"2025-12-29 19:11","pubTimestamp":1767006662,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,杭州德适生物科技股份有限公司(简称:德适生物)于6月29日递交的港股招股书满6个月,于12月29日失效,递表时华泰国际为独家保荐人。招股书显示,根据弗若斯特沙利文资料,德适生物自主研发的iMedImageTM是世界上参数规模最大的通用型医学影像基座模型,已成功实现商业化,而且被认定为世界上首个商业化跨模态医学影像基座模型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["91016"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/91016\",params:#limit:6,delay:false,,,undefined,":[]}}